Back to 
Carlyle Group Inc.
Carlyle Group Inc.SPSPRB
Showing 4 of 10 quarters
Position history for Carlyle Group Inc.'s holdings in Spruce Biosciences, Inc.
As of its Q1 2025 13F, Carlyle Group held 2,896,518 shares of SPRB (Spruce Biosciences), worth $840,280. Carlyle Group's 13F filings listed SPRB from Q1 2023 to Q1 2025, 9 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.3M
Total Shares Change
-2.9M
Quarter-by-Quarter History